BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, raised the proposed deal size for its upcoming IPO on Tuesday.The Buffalo Grove, IL-based company now plans to raise $10 million by offering 1.6 million units at a...read more
BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, lowered the proposed deal size for its upcoming IPO on Thursday.The Buffalo Grove, IL-based company now plans to raise $8 million by offering 1.3 million units at a...read more
BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, raised the proposed deal size for its upcoming IPO on Monday.The Buffalo Grove, IL-based company now plans to raise $22 million by offering 3.6 million units at a...read more
BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, announced terms for its IPO on Tuesday.The Buffalo Grove, IL-based company plans to raise $15 million by offering 2.4 million units at a price range of $5.20 to $7.20. ...read more
Nano-cap BIOLIFE4D increases unit offering by 24% ahead of $10 million IPO
BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, raised the proposed deal size for its upcoming IPO on Tuesday.The Buffalo Grove, IL-based company now plans to raise $10 million by offering 1.6 million units at a...read more
Synthetic heart developer BIOLIFE4D slashes unit offering by 64% ahead of $8 million IPO
BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, lowered the proposed deal size for its upcoming IPO on Thursday.The Buffalo Grove, IL-based company now plans to raise $8 million by offering 1.3 million units at a...read more
Synthetic heart developer BIOLIFE4D ups proposed unit offering by 50% ahead of $22 million IPO
BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, raised the proposed deal size for its upcoming IPO on Monday.The Buffalo Grove, IL-based company now plans to raise $22 million by offering 3.6 million units at a...read more
Synthetic heart developer BIOLIFE4D sets terms for $15 million IPO, offering units
BIOLIFE4D, which is developing synthetic human hearts by utilizing 3D bioprinting technology, announced terms for its IPO on Tuesday.The Buffalo Grove, IL-based company plans to raise $15 million by offering 2.4 million units at a price range of $5.20 to $7.20. ...read more